Sanitas Diagnosztikai és Rehabilitációs Központ
- Address
- Bicere u. 14-16, H-5700 Gyula, Hungary
Sanitas Diagnosztikai és Rehabilitációs Központ
Sanitas Diagnosztikai és Rehabilitációs Központ is a comprehensive diagnostic and rehabilitation center specializing in pediatric respiratory health research. The facility focuses on investigating preventive and therapeutic interventions for children suffering from recurrent respiratory conditions, with particular emphasis on vulnerable pediatric populations aged 6 months to 5 years.
- Recurrent respiratory tract infections (RTIs) in pediatric populations
- Wheezing lower respiratory illness management and prevention
- Immunomodulatory therapeutic approaches in early childhood respiratory disease
The center's research portfolio demonstrates expertise in conducting long-term clinical trials examining the efficacy of preventive immunotherapy in reducing the frequency and severity of recurrent respiratory tract infections in young children. Their work contributes valuable evidence toward improving outcomes for children with wheezing lower respiratory illness, addressing a significant public health concern that affects quality of life and development in the critical early years of childhood.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sanitas Diagnosztikai és Rehabilitációs Központ
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of OM-85 in Preventing Recurrent Respiratory Tract Infections with Wheezing in Children Aged 6 Months to 5 Years: A Randomized, Double-Blind, Placebo-Controlled Study | OM Pharma SA | Phase III | Not Recruiting | Nov 2022 | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.